Federal Cannabis Complaint

Sign the agreement The Concept of Legal Procedure and Litigation.

In 2017, Hiller, PC (along with co-counsel) commenced an action in the Southern District of New York on behalf of two young children (who rely on medical cannabis to treat their medical conditions), their fathers, an American military veteran, a retired football player and a non-profit organization – all of whom have suffered harm by the Controlled Substances Act (“CSA”), seeking a declaration that the CSA’s classification of Cannabis as a Schedule I drug is unconstitutional because, among other things, it violates the Due Process Clause of the Fifth Amendment along with other protections guaranteed by the United States Constitution. The lawsuit argues in part that Cannabis should not be classified as a Schedule I drug (with the likes of heroin, mescaline and LSD) because it: (i) does not have a high potential for abuse; (ii) clearly has a medical use in treatment; and (iii) can, and has, been used or tested safely under medical supervision. Paragraphs 6 through 24 of the Amended Complaint contain an overview of the claims made against the U.S. Government.